Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Safety and Effectiveness of the Vascular Closure Device for Femoral Artery Hemostasis in Patients of Femoral Artery Puncture

NCT07279220 is registered in ClinicalTrials.gov with Shanghai Bomaian Medical Technology Co., Ltd as lead sponsor.

NCT NCT07279220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07279220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Safety and Effectiveness of the Vascular Closure Device for Femoral Artery Hemostasis in Patients of Femoral Artery Puncture
Lead sponsor
Shanghai Bomaian Medical Technology Co., Ltd
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 29, 2025
Completion date
May 15, 2026
Enrollment
238 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

femoral artery puncture, hemostasis, vascular closure device